Timothy H. Lucas, II, MD, PhD, an assistant professor of Neurosurgery and director of the Translational Neuromodulation Lab in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the 2017 Fellow in Leadership Award by Alpha Omega Alpha national medical honor society.
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) – through the use of a contrast agent that makes tumor cells glow during surgery – with preoperative positron emission tomography (PET) scans.
The Penn Center for Precision Medicine (PCPM) Accelerator Fund awarded eight research teams from Penn Medicine in their second round of funding for the implementation of personalized medicine projects across a range of clinical specialties, from dermatology and psychiatry to radiology and cardiology.
Benjamin L. Prosser, PhD, an assistant professor of Physiology, in the Perelman School of Medicine at the University of Pennsylvania, has received the Outstanding Early Career Investigator Award from the American Heart Association’s (AHA) Council on Basic Cardiovascular Sciences, one of its scientific divisions.
Women undergoing daily radiation therapy for breast cancer are commonly told they should not use antiperspirant for fear that it could cause greater radiation damage to the skin, but a new study from the Perelman School of Medicine at the University of Pennsylvania shows that advice is not based on sound science.
Offering $100 to patients eligible for a preventive colonoscopy screening more than doubled the rate of screening when compared to a simple emailed request, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
With more than 117,000 people awaiting a lifesaving organ transplant, Organ Procurement Organizations work very hard to identify as many organ donors as possible to help save these lives. But according to a study published today in the American Journal of Transplantation, there seem to be significant differences in the results of these efforts.
Genetically modified “hunter” T cells successfully migrated to and penetrated a deadly type of brain tumor known as glioblastoma (GBM) in a clinical trial of the new therapy, but the cells triggered an immunosuppressive tumor microenvironment and faced a complex mutational landscape that will need to be overcome to better treat this aggressive cancer.
Three new gene variants, found in a genome wide association study of Alzheimer’s disease (AD), point to the brain’s immune cells in the onset of the disorder. These genes encode three proteins that are found in microglia, cells that are part of the brain’s injury response system.
In a study that could explain why some breast cancers are more aggressive than others, researchers say they now understand how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.
For Patients and the General Public: